Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-10

Clinical Trial Update: A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder Patients [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluated lithium exposure before and during topiramate dosing in patients with bipolar disorder to assess potential drug-drug i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate (Lithium carbonate)
  • Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorder | Phase 1 | Status: COMPLETED